REQUEST A DEMO
Total
USD $0.00
Search more companies

Zagros Pharmed Pars Pharmaceuticals Company Public Joint Stock (Damloran Pharmaceutical Co.) (Iran)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Zagros Pharmed Pars Pharmaceuticals Company Public Joint Stock Profile Updated: March 10, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Zagros Pharmed Pars Pharmaceuticals Company Public Joint Stock (Damloran Pharmaceutical Co.) is a company based in Iran, with its head office in Tehran. It operates in the Pharmaceutical Preparation Manufacturing industry. The enterprise was incorporated on April 04, 1983. Zagros Pharmed Pars Pharmaceuticals Company Public Joint Stock (Damloran Pharmaceutical Co.) currently employs 235 (2025) people. In Q2C2026, the company reported a net sales revenue increase of 27.9%. Over the same period, its total assets grew by 23.61%. In 2026, Zagros Pharmed Pars Pharmaceuticals Company Public Joint Stock (Damloran Pharmaceutical Co.)’s net profit margin increased by 3.98%.

Legal Address
18 Km Of Makhsous Karaj Road, Daroupakhsh Street, Pharmaceutical Factories - The Second Door Of Houses
Tehran; Tehran; Postal Code: 1397116396

Contact Details: Purchase the Zagros Pharmed Pars Pharmaceuticals Company Public Joint Stock (Damloran Pharmaceutical Co.) report to view the information.

Website: http://www.zagrospharmed.com

Basic Information
Total Employees:
Purchase the Zagros Pharmed Pars Pharmaceuticals Company Public Joint Stock (Damloran Pharmaceutical Co.) report to view the information.
Outstanding Shares:
Purchase the Zagros Pharmed Pars Pharmaceuticals Company Public Joint Stock (Damloran Pharmaceutical Co.) report to view the information.
Financial Auditors:
Purchase the Zagros Pharmed Pars Pharmaceuticals Company Public Joint Stock (Damloran Pharmaceutical Co.) report to view the information.
Incorporation Date:
April 04, 1983
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
47.46%
Purchase this report to view the information.
34.45%
Purchase this report to view the information.
1.71%
Purchase this report to view the information.
1.48%
Purchase this report to view the information.
0.09%
Subsidiaries
Shirin Darou Company Public Joint Stock
0.1%
Company Performance
Financial values in the chart are available after Zagros Pharmed Pars Pharmaceuticals Company Public Joint Stock (Damloran Pharmaceutical Co.) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
27.9%
Total Operating Revenue
27.89%
Operating Profit
51.91%
EBITDA
48.59%
Net Profit/Loss for the Period
49.67%
Total Assets
23.61%
Total Equity
9.28%
Operating Profit Margin
6.71%
Net Profit Margin
3.98%
Return on Equity (ROE)
8.78%
Debt / Equity
-5549%
Quick Ratio
19.44%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?